SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5a8b'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F3T_A_IPHA901_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 4	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.21A	4f3tA-5a8bA: undetectable	4f3tA-5a8bA: 11.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KUK_A_RBFA201_1 (BLUE-LIGHT PHOTORECEPTOR)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	9 / 12	VAL A 253 ASN A 262 ASN A 286 ARG A 288 GLN A 291 ASN A 319 ASN A 329 ILE A 333 GLN A 350	None FMN A 500 (-3.8A) FMN A 500 (-3.2A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-3.0A) FMN A 500 (-4.2A) None FMN A 500 (-3.9A)	0.48A	4kukA-5a8bA: 19.3	4kukA-5a8bA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KUK_A_RBFA201_1 (BLUE-LIGHT PHOTORECEPTOR)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	8 / 12	VAL A 253 ASN A 262 ASN A 286 CYH A 287 ARG A 288 GLN A 291 ILE A 333 GLN A 350	None FMN A 500 (-3.8A) FMN A 500 (-3.2A) FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) None FMN A 500 (-3.9A)	0.75A	4kukA-5a8bA: 19.3	4kukA-5a8bA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KUK_A_RBFA201_1 (BLUE-LIGHT PHOTORECEPTOR)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	VAL A 253 ASN A 262 ASN A 286 CYH A 287 ASN A 319 ILE A 333	None FMN A 500 (-3.8A) FMN A 500 (-3.2A) FMN A 500 (-3.6A) FMN A 500 (-3.0A) None	1.33A	4kukA-5a8bA: 19.3	4kukA-5a8bA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KUK_A_RBFA201_2 (BLUE-LIGHT PHOTORECEPTOR)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	5 / 9	LEU A 290 VAL A 300 ILE A 303 PHE A 346 GLY A 348	FMN A 500 (-4.0A) None FMN A 500 ( 4.1A) FMN A 500 (-4.8A) FMN A 500 (-3.8A)	0.58A	4kukA-5a8bA: 19.3	4kukA-5a8bA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KUO_A_RBFA500_1 (BLUE-LIGHT PHOTORECEPTOR)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	8 / 12	VAL A 253 ASN A 262 ASN A 286 ARG A 288 GLN A 291 ASN A 319 ASN A 329 GLN A 350	None FMN A 500 (-3.8A) FMN A 500 (-3.2A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-3.0A) FMN A 500 (-4.2A) FMN A 500 (-3.9A)	0.60A	4kuoA-5a8bA: 18.5	4kuoA-5a8bA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KUO_A_RBFA500_1 (BLUE-LIGHT PHOTORECEPTOR)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	7 / 12	VAL A 253 ASN A 262 ASN A 286 CYH A 287 ARG A 288 GLN A 291 GLN A 350	None FMN A 500 (-3.8A) FMN A 500 (-3.2A) FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-3.9A)	0.81A	4kuoA-5a8bA: 18.5	4kuoA-5a8bA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KUO_A_RBFA500_1 (BLUE-LIGHT PHOTORECEPTOR)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	5 / 12	VAL A 253 ASN A 262 ASN A 286 CYH A 287 ASN A 319	None FMN A 500 (-3.8A) FMN A 500 (-3.2A) FMN A 500 (-3.6A) FMN A 500 (-3.0A)	1.35A	4kuoA-5a8bA: 18.5	4kuoA-5a8bA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_A_RBFA201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	7 / 12	ARG A 288 GLN A 291 ILE A 307 ASN A 319 ASN A 329 GLY A 348 GLN A 350	FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-4.2A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.75A	4r38A-5a8bA: 17.8	4r38A-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_A_RBFA201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	CYH A 287 ARG A 288 GLN A 291 ILE A 307 GLY A 348 GLN A 350	FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.92A	4r38A-5a8bA: 17.8	4r38A-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_A_RBFA201_2 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 8	ASN A 286 LEU A 290 VAL A 300 PHE A 346	FMN A 500 (-3.2A) FMN A 500 (-4.0A) None FMN A 500 (-4.8A)	0.80A	4r38A-5a8bA: 17.8	4r38A-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_B_RBFB201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	8 / 12	ASN A 286 ARG A 288 GLN A 291 ILE A 307 ASN A 319 ASN A 329 GLY A 348 GLN A 350	FMN A 500 (-3.2A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-4.2A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.74A	4r38B-5a8bA: 17.7	4r38B-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_B_RBFB201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	7 / 12	ASN A 286 CYH A 287 ARG A 288 GLN A 291 ILE A 307 GLY A 348 GLN A 350	FMN A 500 (-3.2A) FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.90A	4r38B-5a8bA: 17.7	4r38B-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_B_RBFB201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	ASN A 286 CYH A 287 ARG A 288 ILE A 307 ASN A 319 GLY A 348	FMN A 500 (-3.2A) FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-3.8A)	1.31A	4r38B-5a8bA: 17.7	4r38B-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_C_RBFC201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	7 / 12	ARG A 288 GLN A 291 ILE A 307 ASN A 319 ASN A 329 GLY A 348 GLN A 350	FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-4.2A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.76A	4r38C-5a8bA: 17.7	4r38C-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_C_RBFC201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	CYH A 287 ARG A 288 GLN A 291 ILE A 307 GLY A 348 GLN A 350	FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.93A	4r38C-5a8bA: 17.7	4r38C-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_D_RBFD201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	7 / 12	ARG A 288 GLN A 291 ILE A 307 ASN A 319 ASN A 329 GLY A 348 GLN A 350	FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-4.2A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.76A	4r38D-5a8bA: 17.8	4r38D-5a8bA: 34.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R38_D_RBFD201_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	CYH A 287 ARG A 288 GLN A 291 ILE A 307 GLY A 348 GLN A 350	FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.95A	4r38D-5a8bA: 17.8	4r38D-5a8bA: 34.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R3A_A_RBFA402_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	ARG A 288 GLN A 291 ILE A 307 ASN A 319 ASN A 329 GLN A 350	FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-4.2A) FMN A 500 (-3.9A)	0.57A	4r3aA-5a8bA: 14.1	4r3aA-5a8bA: 18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R3A_A_RBFA402_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	CYH A 287 ARG A 288 GLN A 291 ILE A 307 ASN A 319 GLN A 350	FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-3.0A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-3.9A)	0.85A	4r3aA-5a8bA: 14.1	4r3aA-5a8bA: 18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R3A_B_RBFB402_1 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	5 / 10	ASN A 286 LEU A 290 GLN A 291 VAL A 300 PHE A 346	FMN A 500 (-3.2A) FMN A 500 (-4.0A) FMN A 500 (-3.0A) None FMN A 500 (-4.8A)	0.78A	4r3aB-5a8bA: 14.0	4r3aB-5a8bA: 18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R3A_B_RBFB402_2 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	ARG A 288 ILE A 307 ASN A 319 ASN A 329 GLY A 348 GLN A 350	FMN A 500 (-4.1A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-4.2A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.53A	4r3aB-5a8bA: 14.0	4r3aB-5a8bA: 18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R3A_B_RBFB402_2 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	6 / 12	CYH A 287 ARG A 288 ILE A 307 ASN A 319 GLY A 348 GLN A 350	FMN A 500 (-3.6A) FMN A 500 (-4.1A) FMN A 500 (-4.8A) FMN A 500 (-3.0A) FMN A 500 (-3.8A) FMN A 500 (-3.9A)	0.81A	4r3aB-5a8bA: 14.0	4r3aB-5a8bA: 18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5O_A_IPHA906_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 5	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.22A	4w5oA-5a8bA: undetectable	4w5oA-5a8bA: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5Q_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 4	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.23A	4w5qA-5a8bA: undetectable	4w5qA-5a8bA: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5R_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 4	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.21A	4w5rA-5a8bA: undetectable	4w5rA-5a8bA: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5T_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 4	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.19A	4w5tA-5a8bA: undetectable	4w5tA-5a8bA: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WOZ_B_MN9B401_0 (N-ACETYLNEURAMINATE LYASE)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 6	SER A 278 LEU A 279 ASP A 280 LEU A 272	None	0.74A	4wozA-5a8bA: undetectable 4wozB-5a8bA: undetectable	4wozA-5a8bA: 20.40 4wozB-5a8bA: 20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4C_A_IPHA905_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 5	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.23A	4z4cA-5a8bA: undetectable	4z4cA-5a8bA: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4D_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 5	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.22A	4z4dA-5a8bA: undetectable	4z4dA-5a8bA: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4E_A_IPHA906_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 5	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.22A	4z4eA-5a8bA: undetectable	4z4eA-5a8bA: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4G_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 4	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.20A	4z4gA-5a8bA: undetectable	4z4gA-5a8bA: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KI6_A_IPHA902_0 (PROTEIN ARGONAUTE-2)	5a8b	PTAUREO1A LOV2 DOMAIN (Phaeodactylum tricornutum)	4 / 4	PHE A 241 VAL A 349 ALA A 334 PHE A 331	None None None FMN A 500 (-3.7A)	1.21A	5ki6A-5a8bA: undetectable	5ki6A-5a8bA: 11.48

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["4F3T_A_IPHA901_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.21A","4f3tA-5a8bA:undetectable","4f3tA-5a8bA:11.48"],["4KUK_A_RBFA201_1","BLUE-LIGHT PHOTORECEPTOR","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",9,"VAL A 253;ASN A 262;ASN A 286;ARG A 288;GLN A 291;ASN A 319;ASN A 329;ILE A 333;GLN A 350","None;FMN A 500 (-3.8A);FMN A 500 (-3.2A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-3.0A);FMN A 500 (-4.2A);None;FMN A 500 (-3.9A)","0.48A","4kukA-5a8bA:19.3","4kukA-5a8bA:36.36"],["4KUK_A_RBFA201_1","BLUE-LIGHT PHOTORECEPTOR","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",8,"VAL A 253;ASN A 262;ASN A 286;CYH A 287;ARG A 288;GLN A 291;ILE A 333;GLN A 350","None;FMN A 500 (-3.8A);FMN A 500 (-3.2A);FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);None;FMN A 500 (-3.9A)","0.75A","4kukA-5a8bA:19.3","4kukA-5a8bA:36.36"],["4KUK_A_RBFA201_1","BLUE-LIGHT PHOTORECEPTOR","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"VAL A 253;ASN A 262;ASN A 286;CYH A 287;ASN A 319;ILE A 333","None;FMN A 500 (-3.8A);FMN A 500 (-3.2A);FMN A 500 (-3.6A);FMN A 500 (-3.0A);None","1.33A","4kukA-5a8bA:19.3","4kukA-5a8bA:36.36"],["4KUK_A_RBFA201_2","BLUE-LIGHT PHOTORECEPTOR","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",5,"LEU A 290;VAL A 300;ILE A 303;PHE A 346;GLY A 348","FMN A 500 (-4.0A);None;FMN A 500 ( 4.1A);FMN A 500 (-4.8A);FMN A 500 (-3.8A)","0.58A","4kukA-5a8bA:19.3","4kukA-5a8bA:36.36"],["4KUO_A_RBFA500_1","BLUE-LIGHT PHOTORECEPTOR","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",8,"VAL A 253;ASN A 262;ASN A 286;ARG A 288;GLN A 291;ASN A 319;ASN A 329;GLN A 350","None;FMN A 500 (-3.8A);FMN A 500 (-3.2A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-3.0A);FMN A 500 (-4.2A);FMN A 500 (-3.9A)","0.60A","4kuoA-5a8bA:18.5","4kuoA-5a8bA:36.36"],["4KUO_A_RBFA500_1","BLUE-LIGHT PHOTORECEPTOR","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",7,"VAL A 253;ASN A 262;ASN A 286;CYH A 287;ARG A 288;GLN A 291;GLN A 350","None;FMN A 500 (-3.8A);FMN A 500 (-3.2A);FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-3.9A)","0.81A","4kuoA-5a8bA:18.5","4kuoA-5a8bA:36.36"],["4KUO_A_RBFA500_1","BLUE-LIGHT PHOTORECEPTOR","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",5,"VAL A 253;ASN A 262;ASN A 286;CYH A 287;ASN A 319","None;FMN A 500 (-3.8A);FMN A 500 (-3.2A);FMN A 500 (-3.6A);FMN A 500 (-3.0A)","1.35A","4kuoA-5a8bA:18.5","4kuoA-5a8bA:36.36"],["4R38_A_RBFA201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",7,"ARG A 288;GLN A 291;ILE A 307;ASN A 319;ASN A 329;GLY A 348;GLN A 350","FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-4.2A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.75A","4r38A-5a8bA:17.8","4r38A-5a8bA:34.57"],["4R38_A_RBFA201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"CYH A 287;ARG A 288;GLN A 291;ILE A 307;GLY A 348;GLN A 350","FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.92A","4r38A-5a8bA:17.8","4r38A-5a8bA:34.57"],["4R38_A_RBFA201_2","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"ASN A 286;LEU A 290;VAL A 300;PHE A 346","FMN A 500 (-3.2A);FMN A 500 (-4.0A);None;FMN A 500 (-4.8A)","0.80A","4r38A-5a8bA:17.8","4r38A-5a8bA:34.57"],["4R38_B_RBFB201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",8,"ASN A 286;ARG A 288;GLN A 291;ILE A 307;ASN A 319;ASN A 329;GLY A 348;GLN A 350","FMN A 500 (-3.2A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-4.2A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.74A","4r38B-5a8bA:17.7","4r38B-5a8bA:34.57"],["4R38_B_RBFB201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",7,"ASN A 286;CYH A 287;ARG A 288;GLN A 291;ILE A 307;GLY A 348;GLN A 350","FMN A 500 (-3.2A);FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.90A","4r38B-5a8bA:17.7","4r38B-5a8bA:34.57"],["4R38_B_RBFB201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"ASN A 286;CYH A 287;ARG A 288;ILE A 307;ASN A 319;GLY A 348","FMN A 500 (-3.2A);FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-3.8A)","1.31A","4r38B-5a8bA:17.7","4r38B-5a8bA:34.57"],["4R38_C_RBFC201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",7,"ARG A 288;GLN A 291;ILE A 307;ASN A 319;ASN A 329;GLY A 348;GLN A 350","FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-4.2A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.76A","4r38C-5a8bA:17.7","4r38C-5a8bA:34.57"],["4R38_C_RBFC201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"CYH A 287;ARG A 288;GLN A 291;ILE A 307;GLY A 348;GLN A 350","FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.93A","4r38C-5a8bA:17.7","4r38C-5a8bA:34.57"],["4R38_D_RBFD201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",7,"ARG A 288;GLN A 291;ILE A 307;ASN A 319;ASN A 329;GLY A 348;GLN A 350","FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-4.2A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.76A","4r38D-5a8bA:17.8","4r38D-5a8bA:34.57"],["4R38_D_RBFD201_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"CYH A 287;ARG A 288;GLN A 291;ILE A 307;GLY A 348;GLN A 350","FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.95A","4r38D-5a8bA:17.8","4r38D-5a8bA:34.57"],["4R3A_A_RBFA402_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"ARG A 288;GLN A 291;ILE A 307;ASN A 319;ASN A 329;GLN A 350","FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-4.2A);FMN A 500 (-3.9A)","0.57A","4r3aA-5a8bA:14.1","4r3aA-5a8bA:18.68"],["4R3A_A_RBFA402_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"CYH A 287;ARG A 288;GLN A 291;ILE A 307;ASN A 319;GLN A 350","FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-3.0A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-3.9A)","0.85A","4r3aA-5a8bA:14.1","4r3aA-5a8bA:18.68"],["4R3A_B_RBFB402_1","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",5,"ASN A 286;LEU A 290;GLN A 291;VAL A 300;PHE A 346","FMN A 500 (-3.2A);FMN A 500 (-4.0A);FMN A 500 (-3.0A);None;FMN A 500 (-4.8A)","0.78A","4r3aB-5a8bA:14.0","4r3aB-5a8bA:18.68"],["4R3A_B_RBFB402_2","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"ARG A 288;ILE A 307;ASN A 319;ASN A 329;GLY A 348;GLN A 350","FMN A 500 (-4.1A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-4.2A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.53A","4r3aB-5a8bA:14.0","4r3aB-5a8bA:18.68"],["4R3A_B_RBFB402_2","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",6,"CYH A 287;ARG A 288;ILE A 307;ASN A 319;GLY A 348;GLN A 350","FMN A 500 (-3.6A);FMN A 500 (-4.1A);FMN A 500 (-4.8A);FMN A 500 (-3.0A);FMN A 500 (-3.8A);FMN A 500 (-3.9A)","0.81A","4r3aB-5a8bA:14.0","4r3aB-5a8bA:18.68"],["4W5O_A_IPHA906_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.22A","4w5oA-5a8bA:undetectable","4w5oA-5a8bA:11.48"],["4W5Q_A_IPHA904_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.23A","4w5qA-5a8bA:undetectable","4w5qA-5a8bA:11.48"],["4W5R_A_IPHA904_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.21A","4w5rA-5a8bA:undetectable","4w5rA-5a8bA:11.48"],["4W5T_A_IPHA904_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.19A","4w5tA-5a8bA:undetectable","4w5tA-5a8bA:11.48"],["4WOZ_B_MN9B401_0","N-ACETYLNEURAMINATE LYASE","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"SER A 278;LEU A 279;ASP A 280;LEU A 272","None","0.74A","4wozA-5a8bA:undetectable;4wozB-5a8bA:undetectable","4wozA-5a8bA:20.40;4wozB-5a8bA:20.40"],["4Z4C_A_IPHA905_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.23A","4z4cA-5a8bA:undetectable","4z4cA-5a8bA:11.48"],["4Z4D_A_IPHA904_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.22A","4z4dA-5a8bA:undetectable","4z4dA-5a8bA:11.48"],["4Z4E_A_IPHA906_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.22A","4z4eA-5a8bA:undetectable","4z4eA-5a8bA:11.48"],["4Z4G_A_IPHA904_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.20A","4z4gA-5a8bA:undetectable","4z4gA-5a8bA:11.48"],["5KI6_A_IPHA902_0","PROTEIN ARGONAUTE-2","5a8b","PTAUREO1A LOV2 DOMAIN","Phaeodactylum tricornutum",4,"PHE A 241;VAL A 349;ALA A 334;PHE A 331","None;None;None;FMN A 500 (-3.7A)","1.21A","5ki6A-5a8bA:undetectable","5ki6A-5a8bA:11.48"]]